| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 14 | 2022 | 182 | 3.140 |
Why?
|
| Superoxide Dismutase | 11 | 2018 | 177 | 1.780 |
Why?
|
| Superoxide Dismutase-1 | 6 | 2019 | 48 | 1.230 |
Why?
|
| Theilovirus | 5 | 2019 | 39 | 0.920 |
Why?
|
| Neurons | 15 | 2013 | 1546 | 0.810 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 236 | 0.730 |
Why?
|
| Protein Phosphatase 1 | 1 | 2019 | 34 | 0.720 |
Why?
|
| Single-Chain Antibodies | 1 | 2018 | 17 | 0.670 |
Why?
|
| Spinal Cord | 5 | 2018 | 249 | 0.660 |
Why?
|
| Cell Death | 7 | 2018 | 256 | 0.630 |
Why?
|
| RNA, Viral | 5 | 2011 | 327 | 0.620 |
Why?
|
| Viral Proteins | 5 | 2011 | 300 | 0.590 |
Why?
|
| Immunoglobulin Fragments | 1 | 2013 | 23 | 0.460 |
Why?
|
| Mice, Transgenic | 6 | 2019 | 1540 | 0.430 |
Why?
|
| Apoptosis | 10 | 2011 | 1683 | 0.400 |
Why?
|
| Virulence Factors | 1 | 2011 | 108 | 0.380 |
Why?
|
| C9orf72 Protein | 2 | 2021 | 18 | 0.370 |
Why?
|
| Demyelinating Diseases | 4 | 2011 | 68 | 0.360 |
Why?
|
| Mutation | 11 | 2018 | 3967 | 0.300 |
Why?
|
| Animals | 33 | 2021 | 26581 | 0.300 |
Why?
|
| Motor Neurons | 4 | 2021 | 162 | 0.280 |
Why?
|
| Adenoviridae | 7 | 2003 | 345 | 0.270 |
Why?
|
| Oligodendroglia | 2 | 2020 | 123 | 0.270 |
Why?
|
| Poliomyelitis | 2 | 2011 | 28 | 0.270 |
Why?
|
| Adenoviruses, Human | 3 | 1995 | 41 | 0.260 |
Why?
|
| Nucleotides | 2 | 2022 | 95 | 0.260 |
Why?
|
| Mice | 15 | 2019 | 11352 | 0.250 |
Why?
|
| Enzyme Inhibitors | 5 | 2009 | 639 | 0.250 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 1208 | 0.250 |
Why?
|
| Dipeptides | 3 | 2021 | 46 | 0.230 |
Why?
|
| Carboxypeptidases | 1 | 2003 | 35 | 0.230 |
Why?
|
| Protein Biosynthesis | 3 | 2022 | 378 | 0.220 |
Why?
|
| RNA, Double-Stranded | 4 | 1995 | 22 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 3092 | 0.210 |
Why?
|
| Frontotemporal Dementia | 1 | 2021 | 27 | 0.200 |
Why?
|
| Protein Kinases | 5 | 1993 | 209 | 0.190 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 262 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 2232 | 0.190 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2020 | 11 | 0.190 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2020 | 14 | 0.190 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 75 | 0.180 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 223 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 8 | 0.170 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 7 | 0.170 |
Why?
|
| Gliosis | 1 | 2018 | 35 | 0.170 |
Why?
|
| Animals, Newborn | 1 | 2019 | 510 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2020 | 226 | 0.160 |
Why?
|
| Poloxamer | 1 | 2018 | 29 | 0.160 |
Why?
|
| Cell Membrane | 2 | 2018 | 666 | 0.150 |
Why?
|
| Glutamate Carboxypeptidase II | 2 | 2009 | 8 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 371 | 0.150 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2009 | 19 | 0.150 |
Why?
|
| Blotting, Western | 3 | 2013 | 782 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 111 | 0.140 |
Why?
|
| Nucleic Acid Conformation | 3 | 1995 | 332 | 0.140 |
Why?
|
| HEK293 Cells | 4 | 2021 | 615 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2017 | 173 | 0.130 |
Why?
|
| Genetic Vectors | 3 | 1999 | 439 | 0.130 |
Why?
|
| Defective Viruses | 1 | 1995 | 12 | 0.130 |
Why?
|
| Hippocampus | 8 | 2009 | 442 | 0.130 |
Why?
|
| Tibial Nerve | 1 | 1995 | 14 | 0.130 |
Why?
|
| Axonal Transport | 1 | 1995 | 31 | 0.130 |
Why?
|
| Hypoglossal Nerve | 1 | 1995 | 26 | 0.130 |
Why?
|
| Cricetinae | 6 | 2009 | 560 | 0.130 |
Why?
|
| Cerebral Ventricles | 1 | 1995 | 76 | 0.130 |
Why?
|
| Cells, Cultured | 10 | 2020 | 2818 | 0.120 |
Why?
|
| Brain Stem | 1 | 1995 | 165 | 0.120 |
Why?
|
| Humans | 31 | 2022 | 86601 | 0.120 |
Why?
|
| Bacteriophage M13 | 1 | 2013 | 9 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2004 | 41 | 0.120 |
Why?
|
| Rats | 14 | 2009 | 3990 | 0.120 |
Why?
|
| Biotinylation | 1 | 2013 | 41 | 0.110 |
Why?
|
| Cell Line | 7 | 2019 | 2468 | 0.110 |
Why?
|
| Base Sequence | 7 | 2011 | 2330 | 0.110 |
Why?
|
| Cloning, Molecular | 2 | 2013 | 646 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 376 | 0.110 |
Why?
|
| Codon, Initiator | 2 | 2022 | 21 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2019 | 281 | 0.110 |
Why?
|
| Transfection | 8 | 2011 | 896 | 0.110 |
Why?
|
| Chick Embryo | 2 | 2018 | 229 | 0.110 |
Why?
|
| Luminescent Proteins | 3 | 2013 | 144 | 0.110 |
Why?
|
| Schwann Cells | 1 | 2011 | 34 | 0.100 |
Why?
|
| Rodent Diseases | 1 | 2011 | 34 | 0.100 |
Why?
|
| Cell Survival | 4 | 2003 | 969 | 0.100 |
Why?
|
| Molecular Sequence Data | 7 | 2011 | 3030 | 0.100 |
Why?
|
| Male | 7 | 2020 | 40956 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 2 | 2000 | 125 | 0.090 |
Why?
|
| Ion Channel Gating | 2 | 2011 | 324 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2000 | 152 | 0.090 |
Why?
|
| AIDS Dementia Complex | 1 | 2009 | 8 | 0.090 |
Why?
|
| Female | 6 | 2021 | 44507 | 0.090 |
Why?
|
| Organophosphorus Compounds | 1 | 2009 | 55 | 0.090 |
Why?
|
| PC12 Cells | 5 | 2002 | 115 | 0.080 |
Why?
|
| Pyramidal Cells | 3 | 2002 | 80 | 0.080 |
Why?
|
| eIF-2 Kinase | 8 | 1995 | 46 | 0.080 |
Why?
|
| Neoplasms | 1 | 2022 | 2897 | 0.080 |
Why?
|
| Codon | 2 | 2022 | 124 | 0.080 |
Why?
|
| Alanine | 2 | 2021 | 85 | 0.080 |
Why?
|
| Gene Expression | 5 | 2005 | 1284 | 0.070 |
Why?
|
| Enzyme Activation | 5 | 2004 | 692 | 0.070 |
Why?
|
| Electroporation | 1 | 2005 | 55 | 0.070 |
Why?
|
| Chickens | 1 | 2005 | 212 | 0.070 |
Why?
|
| HeLa Cells | 4 | 2011 | 498 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 268 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 1997 | 214 | 0.060 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2004 | 12 | 0.060 |
Why?
|
| Recombinant Proteins | 5 | 1997 | 1014 | 0.060 |
Why?
|
| Protein Folding | 1 | 2005 | 280 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2009 | 301 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2003 | 152 | 0.060 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2022 | 18 | 0.060 |
Why?
|
| Genes, Viral | 2 | 2000 | 116 | 0.060 |
Why?
|
| Time Factors | 4 | 2011 | 5209 | 0.060 |
Why?
|
| DNA Primers | 3 | 2011 | 543 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2022 | 49 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 1999 | 1196 | 0.050 |
Why?
|
| S100 Calcium Binding Protein G | 3 | 1997 | 22 | 0.050 |
Why?
|
| Proline | 1 | 2021 | 57 | 0.050 |
Why?
|
| HIV-1 | 1 | 2002 | 163 | 0.050 |
Why?
|
| Glycine | 1 | 2021 | 90 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 83 | 0.050 |
Why?
|
| Calcium | 3 | 2011 | 1156 | 0.050 |
Why?
|
| Gene Editing | 1 | 2021 | 42 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1993 | 1075 | 0.050 |
Why?
|
| Arginine | 1 | 2021 | 136 | 0.050 |
Why?
|
| Mastadenovirus | 1 | 2000 | 4 | 0.050 |
Why?
|
| Lac Operon | 1 | 2000 | 46 | 0.050 |
Why?
|
| Free Radicals | 2 | 1997 | 73 | 0.050 |
Why?
|
| Protein Binding | 2 | 2017 | 1456 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2000 | 36 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 2426 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 232 | 0.050 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 71 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 1994 | 1376 | 0.040 |
Why?
|
| Receptor, trkA | 1 | 1999 | 14 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 1961 | 0.040 |
Why?
|
| Neurotoxins | 2 | 1997 | 49 | 0.040 |
Why?
|
| Immunophilins | 1 | 1999 | 5 | 0.040 |
Why?
|
| Nerve Growth Factors | 2 | 1999 | 63 | 0.040 |
Why?
|
| Calcineurin | 1 | 1999 | 16 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2000 | 137 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 864 | 0.040 |
Why?
|
| Antioxidants | 2 | 1997 | 223 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2002 | 447 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 116 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 1999 | 470 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 222 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 557 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2018 | 59 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 1999 | 144 | 0.040 |
Why?
|
| Virulence | 1 | 1998 | 271 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 1995 | 927 | 0.040 |
Why?
|
| Immune System | 1 | 1998 | 93 | 0.040 |
Why?
|
| Central Nervous System | 1 | 1998 | 151 | 0.040 |
Why?
|
| Down-Regulation | 1 | 1999 | 504 | 0.040 |
Why?
|
| Superoxides | 1 | 1997 | 73 | 0.040 |
Why?
|
| Chelating Agents | 1 | 1997 | 69 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 411 | 0.040 |
Why?
|
| Family Health | 1 | 1997 | 162 | 0.040 |
Why?
|
| Staurosporine | 1 | 1997 | 33 | 0.040 |
Why?
|
| Kidney | 3 | 1999 | 1241 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 90 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1998 | 315 | 0.040 |
Why?
|
| Synaptic Transmission | 2 | 1996 | 222 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 1997 | 480 | 0.040 |
Why?
|
| Acylation | 1 | 2017 | 38 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 99 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 1994 | 129 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2019 | 579 | 0.040 |
Why?
|
| Trans-Activators | 1 | 1999 | 429 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 2011 | 435 | 0.030 |
Why?
|
| Neuroglia | 2 | 2009 | 104 | 0.030 |
Why?
|
| Neuroprotective Agents | 2 | 2009 | 94 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 2 | 1993 | 1052 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 1995 | 88 | 0.030 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 1995 | 9 | 0.030 |
Why?
|
| Trigeminal Nerve | 1 | 1995 | 18 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 1995 | 62 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1995 | 67 | 0.030 |
Why?
|
| Mutagenesis | 2 | 1995 | 199 | 0.030 |
Why?
|
| Interferons | 2 | 1995 | 133 | 0.030 |
Why?
|
| Tongue | 1 | 1995 | 57 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1995 | 104 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 1995 | 77 | 0.030 |
Why?
|
| Hindlimb | 1 | 1995 | 89 | 0.030 |
Why?
|
| Phosphorylation | 2 | 1994 | 1106 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1995 | 79 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1995 | 307 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2011 | 347 | 0.030 |
Why?
|
| Muscles | 1 | 1995 | 194 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1997 | 381 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 1996 | 203 | 0.030 |
Why?
|
| Maus Elberfeld virus | 1 | 1994 | 34 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1830 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1995 | 265 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1994 | 43 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1995 | 190 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1996 | 460 | 0.030 |
Why?
|
| Middle Aged | 4 | 2021 | 25017 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 2062 | 0.030 |
Why?
|
| Lipoylation | 1 | 2013 | 28 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 1924 | 0.030 |
Why?
|
| Carbazoles | 2 | 2004 | 51 | 0.030 |
Why?
|
| Disulfides | 1 | 2013 | 64 | 0.030 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 1993 | 81 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1993 | 95 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 1993 | 144 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1993 | 72 | 0.030 |
Why?
|
| Synapses | 1 | 1995 | 265 | 0.030 |
Why?
|
| Neuroblastoma | 2 | 2011 | 374 | 0.030 |
Why?
|
| Nasal Polyps | 1 | 1993 | 58 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 188 | 0.030 |
Why?
|
| Cysteine | 1 | 2013 | 135 | 0.030 |
Why?
|
| Calbindin 1 | 3 | 1997 | 11 | 0.030 |
Why?
|
| Calbindins | 3 | 1997 | 19 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 373 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1804 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1992 | 19 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1992 | 33 | 0.030 |
Why?
|
| Models, Structural | 1 | 1991 | 58 | 0.030 |
Why?
|
| Base Composition | 1 | 1991 | 35 | 0.030 |
Why?
|
| Fetus | 1 | 1993 | 226 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1991 | 40 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1993 | 182 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 2011 | 40 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2011 | 120 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2011 | 52 | 0.030 |
Why?
|
| Valine | 1 | 2011 | 69 | 0.030 |
Why?
|
| Indoles | 2 | 2004 | 318 | 0.030 |
Why?
|
| Biophysics | 1 | 2011 | 152 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1993 | 325 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2011 | 134 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 416 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 396 | 0.020 |
Why?
|
| Brain | 1 | 2000 | 2216 | 0.020 |
Why?
|
| Pleural Neoplasms | 1 | 1992 | 188 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2009 | 52 | 0.020 |
Why?
|
| Presenilin-1 | 2 | 1999 | 100 | 0.020 |
Why?
|
| Child | 1 | 2020 | 6926 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2011 | 881 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 3 | 1993 | 303 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 1994 | 1753 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1993 | 1197 | 0.020 |
Why?
|
| Phenotype | 1 | 1994 | 2377 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1219 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 1999 | 1458 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1992 | 1169 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 1041 | 0.020 |
Why?
|
| CHO Cells | 1 | 2004 | 187 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 1992 | 1464 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1991 | 1565 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 192 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 2 | 1997 | 503 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2002 | 17 | 0.010 |
Why?
|
| Cathepsin B | 1 | 2002 | 12 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 25640 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 64 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2002 | 83 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 117 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 87 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 177 | 0.010 |
Why?
|
| Oxidants | 1 | 2002 | 86 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 104 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2002 | 164 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 100 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 153 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2002 | 158 | 0.010 |
Why?
|
| Kinetics | 2 | 1995 | 1513 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 339 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2000 | 17 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2000 | 20 | 0.010 |
Why?
|
| Basilar Artery | 1 | 2000 | 41 | 0.010 |
Why?
|
| Transgenes | 1 | 2000 | 180 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 1999 | 4 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1999 | 10 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 1135 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 2000 | 196 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 85 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1992 | 2261 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1999 | 63 | 0.010 |
Why?
|
| Dogs | 1 | 2000 | 685 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 212 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 113 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 1999 | 123 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 535 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 879 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 262 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 223 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 435 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 1999 | 322 | 0.010 |
Why?
|
| beta Catenin | 1 | 1999 | 251 | 0.010 |
Why?
|
| Proteins | 1 | 1983 | 777 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1997 | 87 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1997 | 157 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 1996 | 12 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1996 | 8 | 0.010 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1996 | 14 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1996 | 50 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1996 | 37 | 0.010 |
Why?
|
| Calcium Channels | 1 | 1997 | 182 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1999 | 673 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 645 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1996 | 207 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 51 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1997 | 502 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 1981 | 0.010 |
Why?
|
| Cardiovirus Infections | 1 | 1994 | 28 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1994 | 145 | 0.010 |
Why?
|
| Radioallergosorbent Test | 1 | 1993 | 8 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 279 | 0.010 |
Why?
|
| Epitopes | 1 | 1994 | 255 | 0.010 |
Why?
|
| Plasmids | 1 | 1994 | 287 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1993 | 83 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 1098 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1995 | 597 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1991 | 10 | 0.010 |
Why?
|
| Epithelium | 1 | 1993 | 319 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1991 | 66 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 173 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 1991 | 65 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1992 | 165 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1994 | 1047 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 1992 | 233 | 0.010 |
Why?
|
| Iron | 1 | 1992 | 164 | 0.010 |
Why?
|
| Sinusitis | 1 | 1993 | 210 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 1920 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1993 | 970 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1999 | 3241 | 0.010 |
Why?
|
| Biopsy | 1 | 1992 | 1161 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1993 | 2705 | 0.000 |
Why?
|
| Aged | 2 | 1993 | 18402 | 0.000 |
Why?
|